> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Covid-19 Drug Development
- URL: https://www.fdaweb.com/guide-on-covid-19-drug-development/
- Published: 2020-05-18T12:00:00.000Z
- Updated: 2026-09-14T16:15:11.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146806

*Federal Register* notice: FDA has issued a final guidance on “Covid-19: Developing Drugs and Biological Products for Treatment or Prevention.” The document describes the agency’s current recommendations regarding Phase 2 or Phase 3 trials for drugs or biological products under development for treating or preventing Covid-19\. It focuses on the patient population, trial design, efficacy endpoints, safety considerations, and statistical considerations for such trials. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2020-10635.pdf?ref=fdaweb.com).